H.R.5926 - Naloxone Guidelines Act of 2018115th Congress (2017-2018)
|Sponsor:||Rep. Keating, William R. [D-MA-9] (Introduced 05/23/2018)|
|Committees:||House - Energy and Commerce|
|Latest Action:||House - 05/23/2018 Referred to the House Committee on Energy and Commerce. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Summary: H.R.5926 — 115th Congress (2017-2018)All Information (Except Text)
Introduced in House (05/23/2018)
Naloxone Guidelines Act of 2018
This bill requires the Department of Health and Human Services to issue guidelines for prescribing an opioid overdose reversal drug (e.g., naloxone).
The guidelines must address issues relating to the distribution, education, and safety of opioid overdose reversal drugs, including:
- co-prescription with an opioid;
- safe dosages;
- prescription for non-patients; and
- standing orders (i.e., orders that allow dispensing without a prescription).